The von Economo neurons (VENs) are large bipolar Layer V projection neurons found chiefly in the anterior cingulate and frontoinsular cortices. Although VENs have been linked to prevalent illnesses such as frontotemporal dementia, autism, and schizophrenia, little is known about VEN identity, including their major projection targets. Here, we undertook a developmental transcription factor expression study, focusing on markers associated with specific classes of Layer V projection neurons. Using mRNA in situ hybridization, we found that VENs prominently express FEZF2 and CTIP2, transcription factors that regulate the fate and differentiation of subcerebral projection neurons, in humans aged 3 months to 65 years. In contrast, few VENs expressed markers associated with callosal or corticothalamic projections. These findings suggest that VENs may represent a specialized Layer V projection neuron for linking cortical autonomic control sites to brainstem or spinal cord regions.
Introduction
Current frameworks for understanding neuronal identity and laminar fate specification in the cerebral cortex have the potential to shed light on neuropsychiatric disorders that feature a vulnerability gradient across neuronal subtypes. The von Economo neurons (VENs), large bipolar Layer V projection neurons found primarily in anterior cingulate (ACC) and frontoinsular (FI) cortices, have been shown to undergo early, selective degeneration in frontotemporal dementia (FTD; Seeley et al. 2006 Seeley et al. , 2012 Seeley 2008 Seeley , 2010 Kim et al. 2012) , and some evidence points to VEN abnormalities in autism and schizophrenia (Simms et al. 2009; Brüne et al. 2010; Santos et al. 2011) . VENs had previously been identified only in largebrained mammals from distant lineages (apes, humans, cetaceans, and elephants), but recent findings suggest that VENs are present in 2 commonly used laboratory primates, macaca mulatta and macaca fasicularis (Evrard et al. 2012) , making studies of VEN hodology feasible for the first time.
VEN identity remains sparsely characterized, including whether the morphologically similar neurons classified as VENs across species share distinctive molecular or connectivity profiles. VENs are filled retrogradely after injections of the carbocyanine dye DiI into the cingulum bundle, show high nonphosphorylated neurofilament levels, lack calcium-binding protein expression, and express the kidney-type glutaminase isoform of the phosphate-activated glutaminase, suggesting that they are excitatory glutamatergic projection neurons (Nimchinsky et al. 1995; Allman et al. 2010 Allman et al. , 2011 Evrard et al. 2012) . VENs differ from neighboring Layer V pyramidal neurons, however, in size, morphology, ontogeny, and phylogeny. For instance, VENs cannot be identified morphologically until gestational week 36 (Allman et al. 2010) , although neurogenesis of human Layer V pyramidal neurons is estimated to take place between gestational weeks 6.5 and 10 (Bayer and Altman 2007) . As neuronal birth and laminar fate are controlled by highly conserved developmental mechanisms, VENs may represent an unusual Layer V pyramidal neuron specialization.
Tools to explore these diverse facets of VEN identity have begun to arise within developmental neuroscience. In utero, neuronally expressed transcription factors presage neuronal destiny, especially with regard to laminar fate and axonal projection targets. We reasoned that a developmental study of VEN transcription factor expression might help clarify the identity of these fascinating and clinically relevant neurons. To focus the analyses, we took a candidate-based approach, studying transcription factors expressed, to varying degrees, by Layer V projection neurons (i.e., SOX5, TBR1, FEZF2, CTIP2, LMO4, and FOXP1) and the chromatin-remodeling factor SATB2 (Arlotta et al. 2005; Molyneaux et al. 2007; Kwan et al. 2008; Lai et al. 2008; Leone et al. 2008; Bedogni et al. 2010; Cederquist et al. 2013) , seeking to provide a preliminary categorization of VENs with regard to their likely projection targets. Genetic studies in mice have shown that crossregulatory interactions between FEZF2, CTIP2, SATB2, and TBR1 regulate neuronal subtype specification in Layer V, largely via repression of alternative fates. For instance, FEZF2 is necessary and sufficient for the differentiation of layer V neurons that project subcortically to the striatum, superior colliculus, basal pons, and spinal cord; CTIP2 is a major downstream effector of FEZF2 Rouaux and Arlotta 2010) . SATB2 expression determines callosal projections, and the segregation of subcortical and callosal projections in Layer V relies on the repression of SATB2 expression by FEZF2 and repression of CTIP2 expression by SATB2 Srinivasan et al. 2012 ). SATB2-positive callosal projection neurons coexpress FOXP1 and LMO4 (Azim et al. 2009; Hisaoka et al. 2010) . TBR1 promotes the identity of corticothalamic neurons and inhibits subcerebral fates, primarily through repressing FEZF2 and CTIP2 transcription (Han et al. 2011; McKenna et al. 2011) . Accordingly, FEZF2/CTIP2, SATB2 and TBR1 are commonly used in mouse cortex as markers for subcerebral, callosal, and corticothalamic neuronal identities, respectively. Our analysis shows that nearly all mature VENs in human FI and ACC express high levels of the subcerebral projection neuron markers FEZF2 and CTIP2, suggesting that VENs represent a large, specialized Layer V projection neuron whose predominant targets will be found below the cerebrum.
Methods

Postmortem Human Brain Tissue
All human brain tissues were provided by the NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, and their use for this study was approved by the University of California at San Francisco Committee on Human Research. We studied brain tissues from 6 subjects, aged 18 days, 100 days, 2 years, 6 years, 32 years, and 65 years. All subjects lacked a clinical history of neurological symptoms or brain injury, and postmortem neuropathological assessment revealed a brain lacking gross pathological changes.
Fresh-frozen tissue blocks from the 2 VEN-rich brain regions, the ACC and FI, were used for mRNA in situ hybridization. All fresh-frozen samples were obtained from the left hemisphere, with the exception of the 6-year-old subject. Formalin-fixed tissue blocks taken from the contralateral ACC and FI were examined in parallel to provide familiarity with VEN morphology in individual subjects across the diverse age span studied. Postmortem interval ranged from 7 to 22 h. pH ranged from 6.6 to 6.9, and RNA integrity numbers in the cerebral cortex ranged from 6.8 to 7.1 among subjects for whom this information was available from the brain bank. Ultimate tissue suitability was determined by performing in situ hybridization pilot studies to confirm mRNA detection and by examining adjacent Nissl-stained sections to confirm the region of interest (ACC and FI), the presence of VENs, and the absence of severe freezing artifacts.
Histology, Immunohistochemistry, and RNA in Situ Hybridization Fresh-frozen tissue was embedded in Tissue-Tek OCT compound (Sakura), cut at 20 μm thickness on a cryostat, and mounted on Fisher Superfrost/Plus slides for RNA in situ hybridization, double fluorescence in situ hybridization and immunohistochemistry, and Nissl staining. Formalin-fixed tissue was sectioned at 50 or 100 μm on a sliding microtome and used for free-floating immunohistochemistry and Nissl staining.
Standard in situ hybridization methods (Palop et al. 2011) were optimized for human fresh-frozen brain tissue. Briefly, the cryostat sections were air-dried for 20 min and fixed with 4% paraformaldehyde in phosphate-buffered saline solution (0.1 M, pH 7.4) for 30 min. Then, sections were briefly digested with proteinase K for 5 min, acetylated, and incubated in hybridization buffer [50% formamide, 5× salt sodium citrate (SSC) buffer, pH 7.0, 5× Denhardt's solution, 0.25 mg/mL salmon sperm DNA, 0.5 mg/mL yeast tRNA) for 3-4 h at room temperature. The slides were incubated horizontally with hybridization buffer containing the digoxigenin-labeled antisense riboprobe (typically at a concentration of 200-400 ng/mL) in a slide humidity incubation box at 68°C for approximately 16 h. Posthybridization stringent wash conditions (i.e., low salt concentration, 0.2× saline-sodium citrate buffer, and high temperature, 68°C) helped to reduce nonspecific binding of probes. The detection of the digoxigenin-labeled RNA probes was done by immunohistochemistry with antidigoxigenin antibodies conjugated to alkaline phosphatase (1:3000, Roche). The in situ-labeled RNA was visualized by light microscopy using a colorimetric detection reagent (5-bromo-4-chloro-3-indolyl-phosphate and nitro blue tetrazolium chromogen) or by fluorescence microscopy using the HNPP/Fast Red TR chromogen.
The RNA digoxigenin probes used were synthesized from human expressed sequence tag clones (Open Biosystems) that were specific for the gene of interest: SOX5 (BE467463), TBR1 (AW026499), FEZF2 (BM807621), CTIP2 (BG697939), SATB2 (AA393182), LMO4 (AI952998), and FOXP1 (AI183585). Our expression data were largely in agreement with published human and mouse expression data and the Allen brain atlas public electronic database (http://www.brain-map.org/).
For combined fluorescence RNA in situ hybridization and immunohistochemistry on frozen sections, the immunohistochemistry was carried out after the in situ hybridization following standard protocols (Palop et al. 2011) . Monoclonal mouse anti-NeuN (1:500; Chemicon) and rabbit monoclonal anti-Satb2 (1:1000; clone number EPNCIR130, Abcam) antibodies were used. Goat antimouse or goat antirabbit fluorescent secondary antibodies, conjugated with Alexa 488 (1:200; Molecular Probes), were used. Immunohistochemistry to detect MAP2 on free-floating 50 or 100 μm thick sections was performed according to standard methods using the antibody mouse anti-MAP2 (2a + 2b; 1:500, Sigma).
Nonstereological counting was used to quantify the percentage of VENs expressing a given transcription factor in Layer Vb of the ACC and FI. We chose a nonstereological quantitative approach because of the relatively low abundance of VENs in the tissue and the thin nature of our sections (20 μm prior to drying), which precludes true stereological estimates since only a single optical focal plane can be resolved. Counts were performed on representative digitized images obtained with a digital camera connected to a Nikon upright fluorescence microscope, using a ×40 objective. All slides were counted by a single examiner blinded to the subject and marker (I.C.). Digitized images were used to define the field of counted cells, and the examiner focused through the captured field and changed magnification as needed to confirm cellular morphology and VEN identity. Selected slides were independently confirmed by a second examiner (W.W.S.) with regard to anatomical context, VEN location and morphology, and the approximate proportion of VENs expressing each marker. Ten specimens from 5 different subjects (6 samples from the ACC, and 4 from the FI) were analyzed. For each specimen and marker, 3-6 cryostat sections were analyzed. Overall, at least 50 VENs were analyzed for each specimen and marker. NeuN immunohistochemistry served to visualize VENs and to distinguish them from neighboring Layer V pyramidal neurons, based on the large and elongated VEN soma and single basal dendrite (Watson et al. 2006) . In situ hybridization signal was read as either positive or negative for each individual VEN. In some instances (i.e., SATB2, TBR1), low and high expression levels of transcripts could be clearly distinguished and were annotated. All sections were counterstained with 4′,6-diamidino-2-phenylindole (DAPI) (Vectashield ® Hard Set™ mounting medium with DAPI, Vector Laboratories) to provide cytoarchitectural context. Some specimens, particularly the ones from aged brains, showed a degree of autofluorescence due to lipofuscin accumulation. Lipofuscin autofluorescent signal was granular and homogeneous, located in the cytoplasm, and emitted a yellow fluorescence when excited with ultraviolet or blue light; these features were dissimilar to the more diffuse, nuclear in situ hybridization signal, allowing clear discrimination between true-positive signal from transcription factor mRNA and false-positive autofluorescent signal due to lipofuscin.
Results
Layer-Specific Expression of SOX5, TBR1, FEZF2, CTIP2, SATB2, LMO4, and FOXP1 in Human Anterior Cingulate and Frontoinsular Cortices ACC and FI are agranular transition zones between periallocortex and pro-isocortex. They feature an absent Layer IV, inconspicuous Layer II, and a prominent Layer V, sublaminated into Va and Vb. Having confirmed these cytoarchitectural features with Nissl staining in all tissue samples examined, we used in situ hybridization to characterize expression patterns of 6 transcription factors, SOX5, TBR1, FEZF2, CTIP2, LMO4, and FOXP1, and the chromatin-remodeling factor SATB2, implicated in the control of cerebral cortex laminar fate and the generation of deep layer projection neurons (Molyneaux et al. 2007; Leone et al. 2008) . We studied the ACC and FI of early postnatal (age 18 and 100 days), late postnatal (age 2 and 6 years), and adult (age 32 and 65 years) human brains (Figs 1-3) . Although previous human studies have described the cortical expression of some of these genes (Hevner 2007; Ip et al. 2011; Saito et al. 2011) , details on their spatio-temporal expression in human ACC and FI are lacking.
SOX5 and TBR1 expression were present in deep layers VI and V (Figs 1 and 2 and not shown). TBR1 showed highest expression in Layer VI, with only a few scattered neurons in Layer V and lower diffuse expression throughout Layers II-IV (Figs 1B,I,P and 2B,I). FEZF2 and CTIP2 were also expressed in Layers VI and V, but compared with TBR1 they showed highest expression in Layer Vb and lower expression in Layer VI. Comparing these markers, CTIP2 expression occupied a more restricted pattern than FEFZ2, with CTIP2-expressing neurons found in Layers Vb and VI, but not in Layer Va In situ mRNA hybridization of TBR1, FEZF2, CTIP2, SATB2, LMO4, and FOXP1 in adjacent sections through the frontoinsula from 6-year-(A-G) and 65-year-old (H-N) subjects. The laminar pattern of transcription factor expression strongly resembled that seen in the ACC (Fig. 1) . Scale bar: 500 μm. (Figs 1 and 2 ). SATB2 and LMO4 were expressed diffusely across Layers II-VI, without obvious laminar specificity at any of the ages analyzed (Figs 1 and 2 ). FOXP1 was expressed in Layers III-VI, with the highest expression in Layer III (Figs 1G, N, U and 2G, N) .
Because the great majority of VENs are located in cortical Layer Vb, we focused our analysis on this region. When comparing the expression of TBR1, FEZF2, CTIP2, and SATB2 within Layer Vb, clusters of large neurons that were FEZF2-and CTIP2-positive were observed (Fig. 3A,C,D) . Infrequent TBR1-positive neurons were also present in Layer Vb, albeit with lower expression levels than those seen in Layer VI neurons (Fig. 3B) . The majority of Layer Vb neurons showed low expression of SATB2, although occasional high expression was observed in scattered neurons (Fig. 3E) .
In summary, our analysis identified restricted expression patterns of SOX5, TBR1, FEZF2, and CTIP2 in deep Layers V/ VI, with TBR1 showing prominent expression in Layer VI, and FEZF2/CTIP2 in Layer Vb. In contrast, SATB2, LMO4, and FOXP1 expression patterns spanned Layers II-VI (Fig. 3F) . Notably, these expression patterns were established at early postnatal stages (i.e., 3 months of age, Fig. 1A -G) and maintained into the aging brain (i.e., 65 years of age, Figs 1O-U and 2H-N) in ACC and FI (Fig. 3F) .
VENs Express High Levels of FEZF2 and CTIP2 and low Levels of SATB2 VENs are concentrated in Layer Vb of the ACC and FI, and some are singly found in Layer Va (Allman et al. 2010 ). At present, VEN-specific cellular or molecular markers are lacking; therefore, VEN identification relies on distinguishing VENs by their large and elongated bipolar somata and their thick and rather symmetrical apical and basal dendrites ( Fig. 4A ; Watson et al. 2006) . In situ hybridization for FEZF2 and CTIP2 revealed large neurons with an elongated morphology reminiscent of VENs in Layer Vb, at postnatal and adult ages (Fig. 4B,C and not shown) . Double fluorescence in situ hybridization for FEZF2 and immunohistochemistry for NeuN confirmed the expression of FEZF2 in neurons with the distinctive VEN morphology (Fig. 4D) . In contrast, such neurons in Layer V expressed low albeit detectable levels of SATB2 transcripts. A few scattered neurons with relatively small and round somata in Layer V showed conspicuous SATB2 expression (Fig. 4E) . Double fluorescence in situ hybridization for FEZF2 and immunohistochemistry for SATB2 revealed complimentary expression of the 2 markers, such that cells with high levels of one marker showed low levels of the other. Double fluorescence immunohistochemistry for SATB2 and in situ hybridization for SATB2 showed similar distribution of the protein and the mRNA, at postnatal and adult stages (not shown). Thus, these results are consistent with VENs expressing high levels of FEZF2 and CTIP2 and low levels of SATB2.
To quantify the percentage of VENs expressing TBR1, FEZF2, CTIP2, SATB2, and LMO4, we performed double fluorescence in situ hybridization for each of these genes and immunohistochemistry for NeuN in ACC and FI from subjects aged 3 months to 6 years ( Fig. 5) . At 3 months of age, neurons with typical VEN morphology showed no expression of TBR1, whereas FEZF2 and CTIP2 were detected in approximately 45-55%, SATB2 was detected at low levels in approximately 33%, and LMO4 was detected in approximately 15% (Fig. 5A,G) . In the 6-year-old subject, a small percentage of VENs (∼10%) appeared to express TBR1, virtually all VENs expressed FEZF2, CTIP2, and LMO4, and approximately 33% of VENs expressed low levels of SATB2. Thus, our analysis showed that all or nearly all mature VENs in human FI and ACC express FEZF2 and CTIP2 at relatively high levels, whereas about one-third of VENs express SATB2, albeit at lower levels. A small percentage of VENs expresses TBR1. LMO4 expression is prominent in VENs, but also in nearly all putative projection neurons across Layers II-VI. This transcription factor expression profile suggests a subcerebral projection neuron identity and raises the possibility that a subset of human VENs may send secondary projections intracortically (Table 1 ). 
Discussion
VENs represent a population of disease-relevant Layer V projection neurons found only in ACC and FI. Here, we studied the molecular identity of the VENs within a developmental neuroscience framework, demonstrating that VENs express FEZF2 and CTIP2, transcription factors essential for the specification of Layer V subcerebral projection neurons. Substantial mouse genetic evidence has shown that FEZF2 is a master gene necessary and sufficient for the differentiation of Layer V neurons that project to the striatum, superior colliculus, basal pons, and spinal cord, whereas CTIP2 is a major downstream effector of FEZF2 Rouaux and Arlotta 2010; Shim et al. 2012; De la Rossa et al. 2013 ). The FEZF2-CTIP2 genetic pathway executes the subcerebral identity largely through mutual repression with SATB2, a promoter of callosal identity, as well as mutual repression with TBR1, a promoter of corticothalamic identity Han et al. 2011; McKenna et al. 2011; Srinivasan et al. 2012 ). Remarkably, when FEZF2 is ectopically expressed in early postmitotic Layer II/III callosal projection neurons, these are reprogrammed to acquire the molecular identity and axonal connectivity of subcerebral projection neurons (Rouaux and Arlotta 2013) . Our data show robust FEZF2 and CTIP2 expression in human VENs emerging within the first year of life and continuing into late adulthood, consistent with roles in establishing and maintaining a subcerebral projection phenotype.
It is intriguing that although virtually all VENs express high levels of FEZF2 and CTIP2, a subset (∼33%) of VENs coexpressed low levels of SATB2, and scarce (10%) VENs expressed TBR1. The expression of SATB2 in mice determines callosal projection identity Britanova et al. 2008) . TBR1 determines the corticothalamic projection fate in Layer VI neurons, although its relatively lower expression in Layers II/III and scattered cells within Layer V appears to regulate the callosal fate downstream of SATB2 (Srinivasan et al. 2012) . Thus, human VENs may be a heterogeneous population comprising projection neurons with diverse targets including the contralateral cortex. Ultimately, how all these genes interact with repressor complexes to fine tune transcription levels and ultimately to shape the final projection identities of VENs is unclear and needs to be addressed experimentally. For instance, it is unclear whether the subset of VENs co-expressing high levels of FEZF2/CTIP2 and low levels of SATB2 may send projecting fibers exclusively to subcortical areas or additionally target intracortical areas. The present work may serve as a guide for future axonal tracer studies that seek to identify VEN projection targets in the macaque.
To which subcerebral regions might VENs project? This question, though not addressed by the present work, has become tractable in light of the recent discovery that cynomolgus and rhesus macaques, both commonly used in axonal tracing experiments, possess VENs in the ACC and FI. Evrard et al. (2012) reported retrograde labeling of scant right FI VENs after Alexa 594 dextran injection into the left FI. These authors also reported left FI VEN filling after left dorsal midinsula injection. These preliminary findings suggest that a subset of VENs may send a callosal axon that connects the VEN populations within the homologous structures of the 2 hemispheres. This hypothesis aligns with our observation that some VENs express a low level of the callosal marker SATB2. Our data, however, suggest that the search for VEN projection targets should include subcortical and subcerebral structures known to receive inputs from the ACC and ventral anterior agranular insula in monkeys. Candidate targets include, but need not be limited to, regions that participate in autonomicvisceral-nociceptive processing, such as the amygdala, hypothalamus, periaqueductal gray matter, parabrachial nucleus, Figure 4 . VENs express high levels of FEZF2 and low levels of SATB2. (A) MAP2 immunohistochemistry highlighting the bipolar morphology of VENs in a representative 50 μm thick formalin-fixed section of the frontoinsula from a 2-year-old subject. (B and C) In situ mRNA hybridization of FEZF2 in 20 μm thick fresh-frozen sections through the ACC from a 2-year-and a 65-year-old subject. White arrowheads point to FEZF2-positive neurons with an elongated soma and a single basal dendrite, resembling VENs. (D-E″) Double fluorescence in situ mRNA hybridization for either FEZF2 or SATB2 (red) and immunohistochemistry for NeuN (green) in representative sections through the frontoinsula from a 6-year-old subject. White arrowheads in D″ point to presumed FEZF2-positive VENs. White arrowheads in E″ point to presumed SATB2-low expressing VENs, whereas the yellow arrowhead points to a SATB2-high expressing small round neuron. (F′F″) Double fluorescence in situ mRNA hybridization for FEZF2 (red) and immunohistochemistry for SATB2 (green) in a representative section through the frontoinsula from a 6-year-old subject. Note the absence of colocalization between FEZF2-high expressing neurons and SATB2-high expressing neurons. Scale bars: A 50 μm; B and C 100 μm; D-F″ 50 μm. Figure 5 . Patterns of transcription factor expression in Layer Vb VENs. (A-F″) Double fluorescence in situ mRNA hybridization for TBR1, FEZF2, CTIP2, SATB2, and LMO4 (red) and immunohistochemistry for NeuN (green) in representative sections of the ACC or frontoinsula from 3-month-, 2-year-, and 6-year-old subjects. High magnification views of Layer Vb are shown. NeuN immunohistochemistry was used to identify VENs and distinguish them from neighboring pyramidal neurons. Yellow arrowheads point to VENs expressing FEZF2, CTIP2, SATB2, or LMO4; white arrowheads point to VENs not expressing TBR1 or SATB2. (G) Percentage of VENs expressing TBR1, FEZF2, CTIP2, SATB2, and LMO4 in Layer Vb of the ACC or frontoinsula from 3-month-and 6-year-old subjects. Blue indicates transcription factor expression; light or dark shades indicate low or high expression levels. TBR1 is expressed in a small proportion of VENs (∼10%) at age of 6 years. FEZF2 and CTIP2 are detected in approximately 45-55% of VENs at 3 months of age, and in virtually all VENs at 6 years of age. SATB2 is detected, albeit at low levels, in 30-40% of VENs. LMO4 is detected in virtually all NeuN-positive neurons at 6 years, including VENs and pyramidal neurons. Scale bar: 100 μm. nucleus of the solitary tract, nucleus ambiguus, and the dorsal motor nucleus of the vagus nerve. Incorporating molecular classification approaches into macaque VEN hodological studies may further inform the conservation of projection target specification mechanisms across mammals.
Future studies will need to determine whether VENs represent a homogenous population that forms a single narrow and targeted projection or an assembly of morphologically similar neurons with diverse projection targets. To address this question may require multiple retrograde tracer injections within a single organism and multicolor in situ hybridization and immunohistochemistry approaches to decode the "molecular logic" (Woodworth et al. 2012; Custo Greig et al. forthcoming;  Macklis personal communication) guiding individual VEN identity. A related question regards whether individual VEN axons may branch in order to reach multiple targets. This possibility would reconcile our observation that all or most VENs express transcription factors associated with subcerebral projection neurons with the evidence that some VENs project across the corpus callosum (Evrard et al. 2012) .
VEN integrity has been studied in several neuropsychiatric disorders (Seeley et al. 2006; Brüne et al. 2010; Santos et al. 2011; Kim et al. 2012; Santillo et al. 2013) , and the present findings can be viewed within the context of working functionalanatomical disease models. VEN loss has been perhaps most convincingly demonstrated in behavioral variant FTD (bvFTD), a neurodegenerative disorder in which the ACC and FI represent early targets . Consistent with the hypothesis that VENs project to subcerebral regions, patients with bvFTD show early loss of intrinsic functional connectivity within the "salience network," a neural system anchored by ACC and FI in which patients show disrupted connectivity to subcortical and brainstem nodes of the network (Zhou et al. 2010) .
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